This announcement is a separate document:
藥明巨諾-B：根據許可及策略聯盟協議授予延長豁免嚴格遵守上市規則第14A.52條及第14A.53條
JW Therapeutics Co.Ltd: GRANT OF EXTENSION OF WAIVER FROM STRICT COMPLIANCE WITH RULES 14A.52 AND 14A.53 OF THE LISTING RULES UNDER THE LICENSE AND STRATEGIC ALLIANCE AGREEMENT
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.